India probes cough syrup deaths amid safety concerns
Indian officials are investigating whether safety failures led to children dying from contaminated cough syrup. Get the latest details on this developing health crisis.
Category : Pharmaceuticals
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Denmark compensates for Novo Nordisk vision loss
Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.
Quebec pharmacists launch legal fight against Bill 2
Quebec pharmacy owners are taking the government to court over Bill 2, calling it a 'serious threat' to their business model and claiming it disrupts negotiation rights.
Teva Launches Global Innovation Platform for Pharma Breakthroughs
Teva Pharmaceutical launches Rise, a global open innovation platform connecting startups with pharma challenges in AI, digital health and smart manufacturing to accelerate patient impact.
GLP-1 Drugs Changing Canadian Food Habits: Study
New research reveals how diabetes medications Ozempic and Wegovy are transforming Canadian shopping patterns and food consumption. Discover the surprising impacts.
Fake Viagra Sold at Toronto Store: Health Canada
Health Canada warns about counterfeit Viagra discovered at a Toronto convenience store. Learn how to identify fake medications and protect your health.
Novo Nordisk rolls out $349 Wegovy cash price early
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
J&J buys Halda Therapeutics for $3.05 billion
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
GLP-1 Drugs and Hair Loss: What You Need to Know
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Ozempic Penis: The Truth Behind Viral Claim
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.
$20M in drugs missing from Health Canada stockpile
Health Canada refuses to explain how $20 million worth of pharmaceuticals vanished from national emergency stockpile. Transparency concerns raised.
Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Alzheimer's Drug Lecanemab Approved in Canada
Health Canada approves breakthrough Alzheimer's drug lecanemab, offering hope for slowing cognitive decline. Learn about eligibility, costs, and prevention strategies.
India orders drugmakers to meet global standards by January
India requires pharmaceutical companies to comply with international quality standards by January 2026 following fatal cough syrup incidents. New regulations aim to restore global confidence in Indian medicines.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Mucinex Brings Mr. Mucus to Canada with 12-Hour Relief
Mucinex introduces its iconic Mr. Mucus character to Canadian consumers, offering proven 12-hour relief from cold and flu symptoms with expanded product availability nationwide.
Canada's Painkiller Shortage Extends Into New Year
Critical shortages of hydromorphone and other essential pain medications continue to plague Canadian pharmacies, leaving patients scrambling as supply chain issues persist.
Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Kimberly-Clark Buys Tylenol Maker in $48.7B Deal
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
Kimberly-Clark Buys Tylenol Maker Kenvue for $4.87B
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Blood Pressure Medication Recall Over Cancer Risk
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Eli Lilly's Weight Loss Drugs Spark Billion-Dollar Bidding War
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Weight-Loss Pill Race Revolutionizes Healthcare Market
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Ex-Pharmacy Manager Guilty, Fined $5K for Multiple Violations
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Kamloops Pharmacist Suspended, Fined $2,500
A Kamloops pharmacist faces consequences after admitting to making false statements to their regulatory body, resulting in a four-month suspension and financial penalty.
Page 3 of 3